Brisbane Breast Cancer Research Workshop
The 2015 Brisbane Breast Cancer Research Workshop will be held at TRI on the 9th November, hosted by TRI and featuring some of the world's top Breast Cancer researchers.
*Details for this event are currently being finalized and confirmed. Please note, changes may occur.
8:45 | Welcome; housekeeping remarks for the day. |
SESSION 1 - IMAGING AND TRANSLATION |
|
9:00 | Carolyn Mountford “Translating Research Discoveries in Imaging” |
9:40 | Peter Malycha “2D spectroscopy to assess women at high risk of breast cancer: Diagnosis, management and possible therapeutic options” |
10:00 | Janine Porter-Steele “women wellness matters” |
10:20 | Janet Davies “Overview of Metro North Hospital and Health Service” |
10:40 | Siemens and HIRF TBA |
10:40 | MORNING TEA |
SESSION 2 - BREAST CANCER RISK FACTORS AND PREVENTION |
|
11.20 | Devika Ganesamoorthy “Non-invasive characterization of cancer genome by deep sequencing analysis of plasma DNA” |
11.40 | Michael Milevskiy "Long-range regulators of HOTAIR as prognostic biomarkers for the stratification of hormone receptor positive breast cancer" |
12.00 | Darrell Bessette “KCNN4, a novel target for the prevention and treatment of breast cancer” |
12.20 | LUNCH & POSTERS |
FEATURED SPECIAL GUEST SEMINAR |
|
13.00 |
Plenary Seminar: Professor Robin L. Anderson. (Auditorium TRI level 2) > Click here for more information about Professor Robin L Anderson's work |
SESSION 3 - BREAST CANCER ETIOLOGY AND THERAPY |
|
13.20 | Rik Thompson “Epithelial Mesenchymal Plasticity and Breast Cancer Metastasis” |
13.40 | Annette Shewan “"Deciphering the role of polarity proteins in tumour heterogeneity and endocrine response" |
14.00 | Iman Azimi – Calcium signalling in hypoxia-associated cellular responses in breast cancer cells |
14.20 | Juliet French “Novel long non-coding RNAs, CUPID1 and CUPID2, at the 11q13 breast cancer risk locus are implicated in DNA damage response” |
14.40 | LUNCH & POSTERS |
SESSION 4 - NOVEL THERAPIES |
|
15.10 | Partha Mitra “Targeting transcriptional regulation of C-MYB by CDK9 inhibitors: A possible therapeutic model for estrogen positive breast cancer” |
15.30 | Fiona Simpson “Novel combination therapies for Her2 positive and triple negative breast cancers” |
15.50 | Murugan Kalimutho “Targeting genomic instability in aggressive breast cancer” |
16.10 | Roberta Mazzieri “Modulating the microenvironment in metastatic breast cancer to explore new combination therapies.” |
16.30 | Business meeting: choice of next location/ date/ organizers. |